Elghawy O, Sussman JH, Yang AG, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
, JAMA Dermatol., 161(6): 2025 ,e250251
Ward RE, Dave N, Pai EL, Colbourn R, Banihashemi A, Nasta SD, Babatunde VD. Methotrexate-associated Peripheral Neuropathy on 18F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis.
, Clin Nucl Med. : 2025 ,Online ahead of print.
Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM. The Association of Epstein-Barr Virus Donor and Recipient Serostatus With Outcomes After Kidney Transplantation : A Retrospective Cohort Study , Ann Intern Med., 178(2): 2025 ,157-166
Stefan Barta, Stephen Schuster, Jakub Svoboda, Jordan Carter, Elise Chong, Daniel Landsburg, Sunita Nasta, Ruchi Patel, Joseph Fraietta, Colin Thomas, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Siciliano, Marco Ruella, Rosemary Mazanet CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T-cell non-Hodgkin lymphoma: A first-in-human phase I clinical trial (NCT06420089 , American Society of Clinical Oncology Annual Meeting, Chicago, IL. : 2025
Saishravan Shyamsundar, Larissa Borys, Sheila Pierson, Mateo Sarmiento Bustamante, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Sunita Nasta, Ariela Noy, Bridget Austin, Joshua Brandstadter, David Fajgenbaum Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2025
Nikita K. Dave, Paola Carvajal, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma
, American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2025
Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
, N Engl J Med. , 392(18): 2025,1824-1835
Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma
, Blood Neoplasia, 2(3): 2025,100102.
Canty EA, Broderick L, Flaherty D, Xavier M, Nasta SD, Dajani L, White AA. First reported case of a spontaneous and healthy pregnancy in a woman with persistent CAR T-cells 5 years after treatment for diffuse large B-cell lymphoma.
, J Immunother Cancer. , 13(4): 2025,e011092
Pierson SK, Brandstadter JD, Torigian D, Bagg A, Lechowicz MJ, Alapat D MD, Casper C, Chadburn A, Chandrakasan S, Dispenzieri A, Fosså A, Hoffmann C, Ide M, Kurzrock R, Mukherjee S, Nasta SD, Navarro JT, Noy A, Oksenhendler E, Sarmiento Bustamante M, Shyamsundar S, Streetly MJ, Wong RSM, Zhang L, Lim MS, Srkalovic G, van Rhee F, Fajgenbaum DC. Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry. , Blood Adv., 9(8): 2025,1952-1965
